VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Free Cash Flow (2010 - 2026)

VivoSim Labs (VIVS) posted quarterly Free Cash Flow of -$2.2 million for Q1 2026, down 9.43% year-over-year from -$2.5 million in Q1 2025, and up 3.17% quarter-over-quarter from -$2.3 million in Q4 2025.

VivoSim Labs (VIVS) Free Cash Flow (2010 - 2026) Analysis & Trends

VivoSim Labs' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

  • In Q1 2026, Free Cash Flow fell 9.43% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$10.8 million (down 14.28% YoY), while the FY2026 annual figure was -$10.8 million, down 14.28% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$2.2 million, up from -$2.3 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$1.6 million in Q1 2022, with the low at -$5.3 million in Q2 2023.
  • The 5-year median for Free Cash Flow is -$2.7 million (2024), against an average of -$2.9 million.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow sank 186.26% in 2023, then surged 48.86% in 2024.
  • VivoSim Labs' Free Cash Flow stood at -$3.1 million in 2022, then decreased by 14.17% to -$3.5 million in 2023, then soared by 48.86% to -$1.8 million in 2024, then dropped by 27.71% to -$2.3 million in 2025, then climbed by 3.17% to -$2.2 million in 2026.
  • Business Quant data shows VIVS's Free Cash Flow at -$2.2 million in Q1 2026, -$2.3 million in Q4 2025, and -$2.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 VivoSim Labs 1.49 Mn 1.49 Mn - -3.24 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.24 Mn
Jun 30, 2026 -3.24 Mn
Mar 31, 2026 -2.23 Mn
Mar 31, 2026 -2.23 Mn
Dec 31, 2025 -2.30 Mn
Dec 31, 2025 -2.30 Mn
Sep 30, 2025 -2.40 Mn
Sep 30, 2025 -2.40 Mn
Jun 30, 2025 -3.90 Mn
Jun 30, 2025 -3.90 Mn
Mar 31, 2025 -2.04 Mn
Mar 31, 2025 -2.04 Mn
Dec 31, 2024 -1.80 Mn
Dec 31, 2024 -1.80 Mn
Sep 30, 2024 -2.66 Mn
Sep 30, 2024 -2.66 Mn
Jun 30, 2024 -2.98 Mn
Jun 30, 2024 -2.98 Mn
Mar 31, 2024 -2.67 Mn
Mar 31, 2024 -2.67 Mn